Roman Maslennikov
Overview
Explore the profile of Roman Maslennikov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
290
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Ivashkin V, Shifrin O, Maslennikov R, Poluektova E, Korolev A, Kudryavtseva A, et al.
BMC Gastroenterol
. 2023 Mar;
23(1):82.
PMID: 36959568
Background: Rifaximin effectively treats symptomatic uncomplicated diverticular disease (SUDD) and has shown eubiotic potential (i.e., an increase in resident microbial elements with potential beneficial effects) in other diseases. This study...
22.
Ivashkin V, Ismailova A, Dmitrieva K, Maslennikov R, Zharkova M, Aliev S, et al.
World J Hepatol
. 2022 Sep;
14(7):1470-1479.
PMID: 36158923
Background: The clinical efficacy and safety of vaccination against novel coronavirus disease 2019 (COVID-19) in patients with cirrhosis have not been evaluated yet. Aim: To evaluate the clinical efficacy and...
23.
Maslennikov R, Efremova I, Ivashkin V, Zharkova M, Poluektova E, Shirokova E, et al.
World J Hepatol
. 2022 Sep;
14(8):1667-1677.
PMID: 36157871
Background: Bacterial translocation exacerbates the hyperdynamic circulation observed in cirrhosis and contributes to a more severe disease course. Probiotics may reduce bacterial translocation and may therefore be useful to redress...
24.
Maslennikov R, Ivashkin V, Alieva A, Poluektova E, Kudryavtseva A, Krasnov G, et al.
World J Hepatol
. 2022 Aug;
14(6):1210-1225.
PMID: 35978666
Background: Gut dysbiosis and changes in body composition (, a decrease in the proportion of muscle mass and an increase in extracellular fluid) are common in cirrhosis. Aim: To study...
25.
Maslennikov R, Ivashkin V, Ufimtseva A, Poluektova E, Ulyanin A
Future Microbiol
. 2022 Apr;
17:653-663.
PMID: 35440149
To assess the impact of infection on the course of COVID-19. The authors included 809 patients with COVID-19 in this retrospective study: 55 had infection, 23 had -negative antibiotic-associated diarrhea...
26.
Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Kudryavtseva A, Krasnov G
World J Gastroenterol
. 2022 Apr;
28(10):1067-1077.
PMID: 35431497
Background: Gut dysbiosis and small intestinal bacterial overgrowth (SIBO) are commonly observed in patients with cirrhosis. Despite the substantial number of articles describing the relations between disorders of gut microbiota...
27.
Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Shirokova E
World J Clin Cases
. 2021 Dec;
9(31):9320-9332.
PMID: 34877269
Recent evidence suggests that the condition of the gut and its microbiota greatly influence the course of liver disease, especially cirrhosis. This introduces the concept of the gut-liver axis, which...
28.
Maslennikov R, Svistunov A, Ivashkin V, Ufimtseva A, Poluektova E, Efremova I, et al.
Medicine (Baltimore)
. 2021 Nov;
100(41):e27528.
PMID: 34731146
Diarrhea is one of the manifestations of the novel coronavirus disease (COVID-19), but it also develops as a complication of massive antibiotic therapy in this disease. This study aimed to...
29.
Ivashkin V, Fomin V, Moiseev S, Brovko M, Maslennikov R, Ulyanin A, et al.
Probiotics Antimicrob Proteins
. 2021 Oct;
15(3):460-468.
PMID: 34643888
The treatment of coronavirus disease (COVID-19) and COVID-19-associated diarrhea remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in the treatment of COVID-19. This was a...
30.
Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Shirokova E
World J Hepatol
. 2021 Oct;
13(9):1154-1166.
PMID: 34630882
The gut-liver axis plays an important role in the pathogenesis of various liver diseases. Probiotics are living bacteria that may be used to correct disorders of this axis. Notable progress...